Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-01-31 00:00:00 ET · period of report 2022-01-27 · accession 0001209191-22-005662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-31 | 2022-01-27 | RLAY | Bergstrom Donald A | Pres, R, D | A - Grant | $0.00 | +65.0K | 109.9K | +144% | $0 |
| D | 2022-01-31 | 2022-01-27 | RLAY | Bergstrom Donald A | Pres, R, D | A - Grant | $0.00 | +129.9K | 129.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-27 | A | A | 64,950 | $0.00 | 109,920 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. (F2) Includes 93,387 shares underlying RSUs. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-01-27 | A | A | 129,900 | $0.00 | 129,900 | D | $20.38 · — to 2032-01-26 | 129,900 Common Stock | (F3) The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date. |